Applications, hearings, determinations, etc.: Salsbury Chemicals, Inc.,

[Federal Register: April 17, 2001 (Volume 66, Number 74)]

[Notices]

[Page 19796-19797]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr17ap01-77]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By notice dated June 7, 2000, and published in the Federal Register on June 22, 2000 (65 FR 38860), Salsbury Chemicals, Inc., 1205 11th Street, Charles City, Iowa 50616-3466, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Amphetamine (1100)......................... II Methylphenidate (1724)..................... II

The firm plans to manufacture amphetamine and methylphenidate for distribution as bulk product.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Salsbury Chemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Salsbury Chemicals, Inc., to ensure that the company's registration is consistent with the public interest.

This investigation included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823

[[Page 19797]]

and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: April 6, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 01-9398Filed4-16-01; 8:45 am]

BILLING CODE 4410-09-M